Kohei Akiyoshi

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site

Hidetoshi Hayashi, Takayasu Kurata, Yuichi Takiguchi et al. · Journal of Clinical Oncology · 2019 · 168 citations

Medicine, Oncology, Pharmacology +16

Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site

Hidetoshi Hayashi, Yuichi Takiguchi, Hironobu Minami et al. · JAMA Oncology · 2020 · 120 citations · Full text

Medicine, Molecular Medicine, Oncology +17

REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients

Kohei Shitara, Takeharu Yamanaka, Tadamichi Denda et al. · Annals of Oncology · 2018 · 87 citations · Full text

Medicine, Oncology, Pharmacology +11

Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary

Junko Tanizaki, Kan Yonemori, Kohei Akiyoshi et al. · Annals of Oncology · 2021 · 73 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Pharmacokinetic parameters from 3‐Tesla DCE‐MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis

Yoshinori Hirashima, Yasuhide Yamada, Ukihide Tateishi et al. · International Journal of Cancer · 2011 · 68 citations

Medicine, Oncology, Pharmacology +17